Column Capital Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$354K Buy
7,289
+2,441
+50% +$130K 0.05% 102
2023
Q2
$274K Hold
4,848
0.04% 115
2023
Q1
$262K Hold
4,848
0.04% 114
2022
Q4
$255K Hold
4,848
0.04% 104
2022
Q3
$229K Hold
4,848
0.05% 107
2022
Q2
$245K Hold
4,848
0.05% 97
2022
Q1
$296K Hold
4,848
0.05% 98
2021
Q4
$319K Hold
4,848
0.06% 95
2021
Q3
$304K Hold
4,848
0.06% 95
2021
Q2
$292K Hold
4,848
0.06% 95
2021
Q1
$267K Hold
4,848
0.06% 95
2020
Q4
$264K Hold
4,848
0.07% 88
2020
Q3
$242K Hold
4,848
0.07% 81
2020
Q2
$213K Buy
+4,848
New +$207K 0.07% 84

Other funds holding IHI

Column Capital Advisors's IHI Position: Q3 2023 in Review

Column Capital Advisors increased its iShares US Medical Devices ETF (IHI) stake by 50% in Q3 2023, buying an estimated $130K and bringing the position to 7,289 shares worth $354K. The position accounts for 0.05% of the portfolio, ranked #102.

Column Capital Advisors first reported a position in IHI in Q2 2020 and has held it in 14 quarters since. 544 funds tracked by Wall St. Rank hold IHI as of Q3 2023.

  • Column Capital Advisors held 7,289 shares of iShares US Medical Devices ETF worth $354K as of Q3 2023.
  • Column Capital Advisors bought 2,441 iShares US Medical Devices ETF shares in Q3 2023, an estimated $130K.
  • iShares US Medical Devices ETF made up 0.05% of Column Capital Advisors's portfolio in Q3 2023, its #102 holding.
  • Column Capital Advisors first reported a position in iShares US Medical Devices ETF in Q2 2020 and has held it in 14 quarters since.
  • 544 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.